pregleda

Chronic Hepatitis: Metabolic, Cholestatic, Viral


Cena:
1.280 din
Stanje: Polovan bez oštećenja
Garancija: Ne
Isporuka: Pošta
Post Express
Lično preuzimanje
Plaćanje: Tekući račun (pre slanja)
Lično
Grad: Kraljevo,
Kraljevo
Prodavac

Macondo (3126)

PREMIUM član
Član je postao Premium jer:
- ima 100 jedinstvenih pozitivnih ocena od kupaca,
- tokom perioda od 6 meseci uplati minimum 20.000 dinara na svoj Limundo račun.

100% pozitivnih ocena

Pozitivne: 4739

  Pošalji poruku

Svi predmeti člana


Kupindo zaštita

Oblast: Ostalo
Godina izdanja: 2007
ISBN: 978-1-4020-6522-4
Jezik: Engleski
Autor: Strani

Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune

Izdavač: Springer
Grupa autora.
Povez: tvrd sa omotom
Broj strana: 253
Ilustrovano.
Sadržaj priložen na slikama.
Odlično očuvana, kao nova.
Uz knjigu je priložen i CD-ROM.

This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developments in the field of chronic hepatitis and its various entities.

In recent decades we have learned how heterogeneous the clinical entity of chronic hepatitis has become. The liver, as the central organ of metabolism and detoxification, is more than ever a target of disease processes evolving from the spread of obesity in the western world. Apart from nonalcoholic steatohepatitis (NASH), alcoholic liver disease is still the most prevalent liver disease in the west. Alcohol-induced liver disease exhibits a broad clinical spectrum from alcoholic steatohepatitis to cirrhosis. Alcoholic hepatitis is a disease entity with a particular poor prognosis. Any liver disease of unknown cause is suspected as being drug-associated. Every new drug metabolized in the liver has the potential to damage the liver. Primary biliary cirrhosis has seen significant progress due to the identification of new risk factors based on new epidemiological studies. Interface hepatitis has become a prognostic marker as well as a therapeutic target. The treatment of autoimmune hepatitis has progressed significantly due to an individualized approach to immunosuppression.

(K-113)

Lično preuzimanje u Kraljevu.
Troškove dostave plaća kupac.
Predmete ne šaljem u inostranstvo i ne šaljem pouzećem!!!

Predmet: 72596273
Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune

Izdavač: Springer
Grupa autora.
Povez: tvrd sa omotom
Broj strana: 253
Ilustrovano.
Sadržaj priložen na slikama.
Odlično očuvana, kao nova.
Uz knjigu je priložen i CD-ROM.

This book is the proceedings of Falk Symposium 157, entitled ‘Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune’, held in Freiburg, Germany, on 10--11 October 2006 (one of three symposia during the XIII Falk Liver Week 2006). It provides up-to-date information on new developments in the field of chronic hepatitis and its various entities.

In recent decades we have learned how heterogeneous the clinical entity of chronic hepatitis has become. The liver, as the central organ of metabolism and detoxification, is more than ever a target of disease processes evolving from the spread of obesity in the western world. Apart from nonalcoholic steatohepatitis (NASH), alcoholic liver disease is still the most prevalent liver disease in the west. Alcohol-induced liver disease exhibits a broad clinical spectrum from alcoholic steatohepatitis to cirrhosis. Alcoholic hepatitis is a disease entity with a particular poor prognosis. Any liver disease of unknown cause is suspected as being drug-associated. Every new drug metabolized in the liver has the potential to damage the liver. Primary biliary cirrhosis has seen significant progress due to the identification of new risk factors based on new epidemiological studies. Interface hepatitis has become a prognostic marker as well as a therapeutic target. The treatment of autoimmune hepatitis has progressed significantly due to an individualized approach to immunosuppression.

(K-113)
72596273 Chronic Hepatitis: Metabolic, Cholestatic, Viral

LimundoGrad koristi kolačiće u statističke i marketinške svrhe. Nastavkom korišćenja sajta smatramo da ste pristali na upotrebu kolačića. Više informacija.